BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8321735)

  • 21. Severe neutropenia due to naproxen therapy in rheumatoid arthritis: a case report and review of literature.
    Kalksma R; Jansen TL; Bruyn GA
    Neth J Med; 2002 Aug; 60(7):289-91. PubMed ID: 12430576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diclofenac/misoprostol: the European clinical experience.
    McKenna F
    J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A patient with an extremely severe immunohaemolytic anemia due to diclofenac].
    Driessen O
    Ned Tijdschr Geneeskd; 2004 Feb; 148(9):450. PubMed ID: 15038209
    [No Abstract]   [Full Text] [Related]  

  • 24. Nonsteroidal anti-inflammatory drugs-induced generalized fixed drug eruption: two cases.
    Bilgili SG; Calka O; Karadag AS; Akdeniz N; Kosem M
    Hum Exp Toxicol; 2012 Feb; 31(2):197-200. PubMed ID: 21677025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
    Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
    Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematologic side effects of drugs.
    Lubran MM
    Ann Clin Lab Sci; 1989; 19(2):114-21. PubMed ID: 2665627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vasculitic skin lesions caused by nonsteroidal anti-inflammatory agents].
    Veraguth AJ; Häuselmann HJ; Hunziker T; Gerber NJ
    Schweiz Med Wochenschr; 1992 Jun; 122(24):923-9. PubMed ID: 1615302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute pancreatitis following naproxen intake.
    Aygencel G; Akbuga B; Keles A
    Eur J Emerg Med; 2006 Dec; 13(6):372. PubMed ID: 17091064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonsteroidal anti-inflammatory drugs and neutropenia.
    Strom BL; Carson JL; Schinnar R; Snyder ES; Shaw M; Lundin FE
    Arch Intern Med; 1993 Sep; 153(18):2119-24. PubMed ID: 8379803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drugs and blood].
    Keiser G
    Schweiz Rundsch Med Prax; 1985 Jan; 74(3):40-5. PubMed ID: 2857497
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective Cyclooxygenase 2 inhibitors: a class effect?
    Hudson M; Rahme E; Richard H; Pilote L
    Arthritis Rheum; 2007 Apr; 57(3):516-23. PubMed ID: 17394181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level.
    Varas-Lorenzo C; Maguire A; Castellsague J; Perez-Gutthann S
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):366-76. PubMed ID: 16897817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug induced thrombocytopenia: a case report.
    Abraham SM
    J Indian Med Assoc; 2011 May; 109(5):347. PubMed ID: 22187774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The postoperative analgesic efficacy and safety of piroxicam (FDDF) and naproxen sodium.
    Selçuk E; Gomel M; Apaydin S; Köse T; Tuglular I
    Int J Clin Pharmacol Res; 1998; 18(1):21-9. PubMed ID: 9604731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ecthyma gangrenosum presenting in diclofenac induced neutropenia.
    Fairhurst DA; Pollock B
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):868-9. PubMed ID: 16898913
    [No Abstract]   [Full Text] [Related]  

  • 38. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E; Nedjar H
    Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury.
    Lafrance JP; Miller DR
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):923-31. PubMed ID: 19585463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naproxen induced thrombocytopenia: a case report.
    Hunt PJ; Gibbons SS
    N Z Med J; 1995 Nov; 108(1012):483-4. PubMed ID: 8538977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.